Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trialJohn Zajicek, Alan J. Thompson, Patrick J. Fox et al.|The Lancet|2003Cited by 828
Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive TuberculosisStephen H. Gillespie, Andrew Nunn|New England Journal of Medicine|2014Cited by 653
New strategies for clinical trials in patients with sepsis and septic shockJonathan B. Cohen, Steven M. Opal, Gordon R. Bernard et al.|Critical Care Medicine|2001Cited by 157
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TBConor Tweed, Stephen H. Gillespie, Janice Caoili et al.|The International Journal of Tuberculosis and Lung Disease|2021Cited by 63